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Introduction
The Public's Health in the Global Era: Challenges,
Responses, and ResponsibilitiesDAVID P. FIDLER**
INTRODUCTION

The Indiana Journal of Global Legal Studies is a forum for scholarly
discourse among the many disciplines that study the phenomenon of
globalization. Each year, the Journal sponsors a major symposium that
concentrates on a specific aspect of globalization to encourage
interdisciplinary analysis and communication in provocative and cutting-edge

areas of research.' This year's Symposium, The Public'sHealth in the Global
Era: Challenges,Responses, and Responsibilities, focuses on the intersection
between health and globalization.
Just as the processes of globalization affect traditional conceptions of
sovereignty, economics, law, and politics, they also affect notions of
individual, national, and international health. The Symposium was organized
to capture three fundamental aspects of the intersection between health and
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globalization: (1) the challenges to public health posed by the globalization
phenomena; (2) the need for and problems confronting the development of
responses to global health challenges; and (3) the importance of thinking about
the public's health in the global era ethically in order to identify and debate
moral responsibilities created by the global challenges and the need for global
responses. The task of addressing these important aspects of health and
globalization was divided amongst three panels, the members of which
analyzed the global challenges, responses, and responsibilities in diverse and
provocative ways. Each panel had a lead paper, followed by one or two
commentaries. The first panel2 examined the globalization of public health
through the analysis of the global crisis posed by emerging infectious diseases.
Once thought conquered, infectious diseases have returned with a vengeance
to confront national and international public health officials with an array of
formidable global challenges.
The second panel' focused on how pharmaceutical companies are dealing
with the pressures of the global market. The development of new drugs for
both infectious and chronic diseases has long been a factor in society's
responses to health threats. Globalization affects pharmaceutical development
dramatically, making an understanding of this area of public health particularly
important.
The third panel" addressed broader questions of justice and ethics raised
by the impact of globalization on health issues. The challenges societies face
confront public health and political officials with both philosophical and
scientific dilemmas. Matters of justice and ethics are critical parts of any
framework created to analyze the choices we face in working to ensure the
public's health in the global era.
I. GLOBAL CHALLENGES: THE GLOBALIZATION OF PUBLIC HEALTH: THE
PROBLEM OF EMERGING INFECTIOUS DISEASES

My paper, The Globalization of Public Health: Emerging Infectious
Diseases and International Relations, attempts to demonstrate that the
processes of globalization have shattered traditional distinctions between

2. Global Challenges: The Globalization of Public Health: The Problem of Emerging Infectious
Diseases.
3. Global Responses: The Search for Cures and the Development of Pharmaceuticals.
4. Global Responsibilities: Justice and Ethics in the Era of Global Public Health.
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national and international public health.
One of the most dramatic
manifestations of the "globalization of public health" is the global crisis of
emerging infectious diseases. I briefly examine the factors behind this crisis
and the contributions made by the processes of globalization to the emergence
and reemergence of infectious diseases. I then develop what I call "the
pathology of the globalization of public health" to provide a more systematic
understanding of the relationship between public health and globalization.
This analysis involves comparing the globalization of public health in the latter
half of the nineteenth century with the late twentieth-century manifestation of
this phenomenon. The pathology of the globalization of public health in the
era of emerging infectious diseases presents a daunting and grim picture for
the public's health in the global era.
The seriousness of the challenge posed by the globalization of public
health leads me to explore how traditional conceptions of international
relations deal with the new pathology of the globalization of public health. I
examine three major international relations traditions-realism, liberalism, and
critical international theory-in order to learn whether any of these traditions
provide any lessons that can be used against emerging infectious diseases.
While each tradition provides insights into the globalization of public health,
it is clear that emerging infectious diseases create serious challenges to
assumptions and preferences embedded in each tradition.
My paper's overall objective is to argue that "[d]ealing with the EID crisis
will have to involve both an understanding of the globalization of public health
and how such globalization challenges our descriptive and normative
frameworks for thinking about international relations." 5
Professor Dennis Pirages picks up the challenge I laid down in his
comment, Ecological Theory and InternationalRelations. Professor Pirages
argues that traditional theories of international relations "fail to acknowledge
even the most basic ecological factors in explaining interstate behavior and the
emergence of global issues."6 He develops an ecological theory of
international relations "that stresses the evolutionary interactions among
human populations, between them and the physical environment, and between
them and pathogenic microorganisms.' 7 Professor Pirages believes that an

5. David Fidler, The Globalizationof Public Health: Emerging Infectious Diseases and International
Relations, 5 IND. J. GLOBAL LEGAL STUD. 11, 11 (1997).
6. Dennis Pirages, Ecological Theory and International Relations, 5 IND. J. GLOBAL LEGAL STUD.
53, 53 (1997).
7. Id. at 56.
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ecological perspective can give international relations theory a grounding in
environmental realities and give such theory predictive power to take into
account and deal with biological threats to human security. The ecoevolutionary approach to international relations, according to Professor
Pirages, helps us understand the technology-driven changes of globalization
because the economic interdependence of the world is accompanied by
ecological interdependence, which creates opportunities for pathogenic
microbes in homogenized and intimately-linked human populations. In ways
not possible through traditional international relations theories, the ecological
approach informs us that "the international management of the epidemiological
consequences of globalization must be one of the highest priorities for the
emerging council of the global village."8
II. GLOBAL RESPONSES: THE SEARCH FOR CURES AND THE DEVELOPMENT
OF PHARMACEUTICALS

Professor Stuart Walker presents in his lead paper the four basic challenges
confronting the global pharmaceutical industry. As the great engine of
research and development for cures and treatments for all types of disease,
private pharmaceutical companies play a critical role in providing for the
public's health in the global era. The health of the global pharmaceutical
industry is, thus, of great concern to those interested in health care and public
health. Professor Walker argues that the four challenges facing the global
pharmaceutical industry are to (1) remain profitable, (2) carry out innovative
research and development, (3) bring new drugs to market more quickly, and
(4) ensure that the drug approval process is rapid and efficient. These
challenges are being met by the pharmaceutical companies in various ways.
For example, the profit challenge has stimulated horizontal integration through
mergers and acquisitions in the global pharmaceutical industry as companies
search for more ways to generate sufficient revenue in an era of cost
containment. Pharmaceutical companies have also pursued vertical strategies
through increasing involvement in prescription management. The innovation
challenge has created an expansion in pharmaceutical companies' willingness
to form alliances and collaborate in research and development. The efficiency
challenge has produced pressures on pharmaceutical companies to reengineer
the drug development process to reduce the time from the first identification
8. Id. at 63.
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of a new molecular entity to first launch in major markets. The regulatory
challenge has to be met, according to Professor Walker, by more collaboration
between governments and industry. He stresses also the interdependence of
each of the challenges, which forces pharmaceutical companies to plan
comprehensively in the global era.
While the challenges are significant, Professor Walker thinks that the
global pharmaceutical industry has stepped to each challenge, although much
remains to be done. He cautions that, while a healthy global pharmaceutical
industry is necessary for global responses to threats to human health, it is not
a sufficient response to the health concerns facing humanity today.
Dr. Louis Lasagna's comment to Professor Walker's paper underscores the
seriousness of the challenges facing the global pharmaceutical industry and
suggests that handling these challenges will be far from easy. Dr. Lasagna
highlights the problems pharmaceutical companies face from upwards cost
pressures created by regulatory approval processes and increasing drug
development expenses. He casts a skeptical eye at strategies of horizontal and
vertical integration in the industry as perhaps representing short-term fixes
rather than long-term solutions to the profitability problem facing
pharmaceutical companies. Dr. Lasagna also sees problems with the new
pharmaceutical R&D technologies as they have yet to achieve great advances
in either cost control or drug innovation. 9 He concludes that the future of the
global pharmaceutical industry is clouded with uncertainties.
Dr. Allan Weinstein's comment stresses the interconnections of the profit
challenge and the innovation challenge. He argues that pharmaceutical
innovation cannot be achieved simply through horizontal or vertical
integration or increased research and development budgets. Dr. Weinstein
believes that innovation is best served by pharmaceutical companies forming
research and development alliances with institutes, universities, and
biotechnology firms and applying new technologies. Regulatory obstacles can
only be overcome through stronger government-industry collaboration on
international harmonization.
The papers on the global pharmaceutical industry demonstrate that the
ability of this industry to continue its search for cures through the development
of pharmaceuticals depends on complex interdependent global dynamics that

9. Louis Lasagna, In Pursuit ofProfitability and Effectiveness in the Global Pharmaceutical Industry,
5 IND. J. GLOBAL LEGAL STUD. 85, 92 (1997).
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involve economics, science, technology, health care changes, and regulatory
policies.

Il.GLOBAL RESPONSIBILITIES: JUSTICE AND ETHICS INTHE ERA OF GLOBAL
PUBLIC HEALTH

In his lead paper Global Responsibilities: Ethics, Public Health, and
Global EnvironmentalChange, philosopher Dale Jamieson explores the ethical
context of the relationship between climate change and public health.
Professor Jamieson establishes the threat that global environmental change, in
the form of global warming, potentially poses to human health. Global
warming threatens public health in a number of ways, but particularly
seriously in connection with infectious diseases. Professor Jamieson notes, for
example, that malaria currently affects 270 million people; but global warming
could expose another 620 million people to this feared parasitic disease. He
explains why the health threat caused by climate change has attracted much
attention while other aspects of global warming have not.
Professor Jamieson then explores the ethical implications of the potential
public health threats of climate change. While the health effects of global
warming may not be felt for years, moral reasoning points to acting today to
prevent foreseeable harm in the future. Professor Jamieson discusses two
paradigms of morality: (1) the causal paradigm, which assigns moral
responsibility to those who cause harm; and (2) the paradigm that assigns
moral responsibility to those in a position to take action to prevent harm. In
the context of global warming and its threat to human health, morality requires
that "those who are in a position to prevent or mitigate climate change are
responsible for doing so regardless of their causal contributions."'" Putting this
moral paradigm into practice requires addressing not only the problem of
climate change, but also "problems of nutrition and sanitation that make
people, mainly 'in developing countries, but also the poor in rich countries,
vulnerable to disease.""
In his comment Global EnvironmentalChange, Health, and the Challenge
for Human Rights, Satvinder Juss argues that consideration of the potential
human threats posed by climate change must include thinking about human

10. Dale Jamieson, Global Responsibilities: Ethics, Public Health, and Global Environmental
Change, 5 IND. J.GLOBAL LEGAL STUD. 99, 118 (1997).
11. Id.at 119.
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rights. However, Juss advocates, the human rights discourse must not only be
included, but also modified to meet the demands of the global environmental
challenges on the horizon. He develops the concept of the "chthonic right",
or "the right of the individual and of communities to live in stability with the
unspoiled environment."' 2
Juss begins his analysis by examining how national governments,
specifically the United States and the United Kingdom, have so far attempted
to deal with global environmental change. The increasing national emphasis
placed on protecting human health leads Juss to explore the "right to health"
that many argue exists in international human rights law. He distinguishes
"health rights" from the "right to health" and looks into the controversies of
each concept. Juss argues that neither health rights nor the right to health has
been developed into a coherent idea. Both raise larger issues that must be
brought into the debate: the nature of economic development and the
condition of the natural environment. At the center of discourse about
economic development and environmental protection is the so-called human
"right to development" in international law, which Juss analyzes.
Finally, Juss argues that all previous human rights controversies show the
limitations of the traditional human rights discourse, which focuses on the state
and what governments do to people. In the era of globalization, non-state
actors and forces also threaten human dignity through the degradation of the
environment and human health. Juss wants the human rights discourse to
move away from the focus on the individual toward a global perspective that
takes into account and balances the individual, community, and the
environment. Juss calls this approach "chthonicism", a philosophy "whereby
mankind curtails his behavior to live in harmony with the ecological society
around him."' 3 It is a philosophy that questions "whether the process of
mankind can always be seen purely in terms of the progress of empirical
science and rationality ofjudgment."' 4 Chthonicism advocates the wisdom of
"traditional knowledge" over "scientific knowledge" in centering humankind
within the natural environment and providing a way for humans to achieve
health dignity.

12. Satvinder Juss, Global Environmental Change, Health and the Challenge for Human Rights, 5
IND. J. GLOBAL LEGAL STUD. 121, 122 (1997).

13. Id.
at 175.
14. Id.at 178.
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The final comment under the third panel comes from Professor Eibe
Riedel and is entitled Global Responsibilities and Bioethics: Reflections on
the Council of Europe's Bioethics Convention. Professor Riedel argues that
the current controversies over genetic engineering raise a very important
ethical challenge facing the public's health in the global era. He focuses on the
European Bioethics Convention because it "provides an excellent case study
of the ethical difficulties states and peoples will face in coming to grips with
the moral implications of the advances in scientific technologies."' 5
Professor Riedel first sets out the opposing philosophical positions that
the
shaped the negotiations of the European Bioethics Convention:
conservative position opposing human manipulation of human embryos and
genes versus the liberal position supporting research on human genetics.
Interestingly, the processes of globalization heavily influenced this
philosophical debate as countries, like Germany, that adopted a conservative
stance, faced the prospect of biotechnology research and development going
off-shore to benefit from the environment provided by countries, like Great
Britain, that have a liberal perspective on bioethics.
Professor Riedel then analyzes the European Bioethics Convention in
detail, pointing out where the treaty language disguises fundamental
controversies about bioethics. In essence, Professor Riedel believes that the
European Bioethics Convention did not resolve the ethical question swirling
around human gene technology and its use. Often, the Convention adopted a
position that "leaves it up to national laws to determine the scope and extent
of gene technology and bioethics."' 6 Globalization factors into this result as
well because it weakens the conservative position vis-6-vis the liberal stance
because of opportunities for German companies, for example, to escape the
restrictive German rules for more accommodating legal regimes elsewhere in
Europe or the world.
Professor Riedel concludes by accepting the applicability of Professor
Jamieson's prevent-harm moral paradigm to the controversy over human gene
technology. He does not believe that the European Bioethics Convention
achieves a harmonized approach to this issue that sets an international preventharm framework in place. Despite its shortcomings, Professor Riedel suggests
that the European Bioethics Convention "is the first frustrating step in the

15. Eibe Riedel, Global Responsibilities and Bioethics: Reflections on the Council of Europe's
Bioethics Convention, 5 IND. J. GLOBAL LEGAL STUD. 179, 179 (1997).
16. Id. at 186.
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needed effort to develop global public interest norms in the area of
bioethics."'7
CONCLUSION

The Symposium's papers raise and analyze a rich and complex set of
issues created by the intersection of health and globalization. The authors
bring to this fascinating topic diverse approaches, from international relations
theory to moral philosophy, and from a pharmaceutical company's bottom line
to global environmental degradation. Health is an intensely individual
concern, and public health has long been a national priority. However, as this
Symposium highlights, personal and public health today are global matters
because globalization helps create health challenges and because our responses
to and responsibilities for these challenges also must be global in ambition and
achievement.

17. Id. at 190.

